In Your 70s? 3 Stocks You Might Want to Buy

Even in your 70s, you may very well have two decades or more ahead of you. That type of potential long-term future means you should really consider owning stocks, even if you're already retired. But not every stock is fit for the portfolio of an investor in their 70s, as it's much more difficult to recover from a severe downturn if you're relying on your portfolio to cover your costs.

The ideal stocks for a 70-something investor are ones that:

  • Have solid balance sheets, improving their chances of withstanding typical economic downturns.

  • Are reasonably valued, helping reduce the downside risk from a market correction.

  • Pay well-covered dividends, providing investors with direct cash rewards for their financial risks.

  • Look capable of growing at least in line with inflation over time, giving investors a chance to protect their buying power.

These three stocks fit the bill, making them worthy of your consideration.

Senior man looknig at a computer screen with growth charts
Senior man looknig at a computer screen with growth charts

Image source: Getty Images.

A healthcare titan with a history of over 130 years of helping others

Johnson & Johnson (NYSE: JNJ) can trace its history back to 1886. A leader in medical devices ranging from bandages to leading-edge robotic surgery, Johnson & Johnson has both a proven track record of success and a path of innovation that should serve it well in the future.

As befitting of an industry titan, Johnson & Johnson has a solid balance sheet with a debt to equity ratio below 0.5 and around $16 billion in cash. That's an incredible war chest to protect it against an economic downturn or to provide capital for acquisitions or research and development. Even with that strong financial foundation, its shares are available at a reasonable price of around 17 times the company's expected future earnings.

With those earnings expected to grow by around 7.8% annualized over the next five years, Johnson & Johnson looks capable of continuing to reward its shareholders. Those shareholders currently receive $0.84 per share per quarter in dividends, for a yield of about 2.3%. That dividend represents less than 60% of the company's earnings, adding to its flexibility and providing room for its dividend to continue to grow as its earnings do over time.

If it squawks like a duck

A white duck with an orange bill, similar to the Aflac spokesduck
A white duck with an orange bill, similar to the Aflac spokesduck

Image source: Getty Images.

Supplemental insurance titan Aflac (NYSE: AFL) may be best known for its famous spokesduck, but the company's quirky advertising certainly doesn't detract from its dominant position in its industry. Aflac is so powerful in Japan's cancer insurance market, for instance, that even the Japanese post office markets its policies. It also happens to be the largest supplemental insurance provider in the United States.